SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950144-07-003266
Filing Date
2007-04-10
Accepted
2007-04-10 15:09:52
Documents
2
Period of Report
2007-05-16
Effectiveness Date
2007-04-10

Document Format Files

Seq Description Document Type Size
1 BIOCRYST PHARMACEUTICALS, INC. g06379ddef14a.htm DEF 14A 407901
2 GRAPHIC g06379dg0637901.gif GRAPHIC 2628
  Complete submission text file 0000950144-07-003266.txt   413122
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 07758760
SIC: 2836 Biological Products, (No Diagnostic Substances)